Glycogen Synthase Kinase 3: A Kinase for All Pathways?

被引:171
作者
Patel, Prital [1 ,2 ]
Woodgett, James R. [1 ,2 ]
机构
[1] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
来源
PROTEIN KINASES IN DEVELOPMENT AND DISEASE | 2017年 / 123卷
关键词
INSULIN-RECEPTOR SUBSTRATE-1; RABBIT SKELETAL-MUSCLE; PROTEIN-KINASE; ALZHEIMERS-DISEASE; TYROSINE PHOSPHORYLATION; MOLECULAR-MECHANISM; GLUCOSE-METABOLISM; SIGNALING PATHWAY; PRECURSOR PROTEIN; STRUCTURAL BASIS;
D O I
10.1016/bs.ctdb.2016.11.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glycogen synthase kinase-3 (GSK-3) is an unusual protein-serine kinase in that it is primarily regulated by inhibition and lies downstream of multiple cell signaling pathways. This raises a variety of questions in terms of its physiological role(s), how signaling specificity is maintained and why so many eggs have been placed into one basket. There are actually two baskets, as there are two isoforms, GSK-3 alpha and beta, that are highly related and largely redundant. Their many substrates range from regulators of cellular metabolism to molecules that control growth and differentiation. In this chapter, we review the characteristics of GSK-3, update progress in understanding the kinase, and try to answer some of the questions raised by its unusual properties. Indeed, the kinase may trigger transformation in our thinking of how cellular signals are organized and controlled.
引用
收藏
页码:277 / +
页数:8
相关论文
共 85 条
[51]   Expression analysis of glycogen synthase kinase-3 in human tissues [J].
Lau, KF ;
Miller, CCJ ;
Anderton, BH ;
Shaw, PC .
JOURNAL OF PEPTIDE RESEARCH, 1999, 54 (01) :85-91
[52]   Insulin transiently increases tau phosphorylation:: Involvement of glycogen synthase kinase-3β and Fyn tyrosine kinase [J].
Lesort, M ;
Jope, RS ;
Johnson, GVW .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (02) :576-584
[53]   Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3β [J].
Li, T ;
Hawkes, C ;
Qureshi, HY ;
Kar, S ;
Paudel, HK .
BIOCHEMISTRY, 2006, 45 (10) :3134-3145
[54]   Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling [J].
Liberman, Z ;
Eldar-Finkelman, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (06) :4422-4428
[55]   A unique type of GSK-3 inhibitor brings new opportunities to the clinic [J].
Licht-Murava, Avital ;
Paz, Rom ;
Vaks, Lilach ;
Avrahami, Limor ;
Plotkin, Batya ;
Eisenstein, Miriam ;
Eldar-Finkelman, Hagit .
SCIENCE SIGNALING, 2016, 9 (454)
[56]   A chaperone-dependent GSK3β transitional intermediate mediates activation-loop autophosphorylation [J].
Lochhead, Pamela A. ;
Kinstrie, Ross ;
Sibbet, Gary ;
Rawjee, Teeara ;
Morrice, Nick ;
Cleghon, Vaughn .
MOLECULAR CELL, 2006, 24 (04) :627-633
[57]   The Wnt signaling pathway in development and disease [J].
Logan, CY ;
Nusse, R .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2004, 20 :781-810
[58]   Glycogen synthase kinase 3α-specific regulation of murine hepatic glycogen metabolism [J].
MacAulay, Katrina ;
Doble, Bradley W. ;
Patel, Satish ;
Hansotia, Tanya ;
Sinclair, Elaine M. ;
Drucker, Daniel J. ;
Nagy, Andras ;
Woodgett, James R. .
CELL METABOLISM, 2007, 6 (04) :329-337
[59]   A feasibility and tolerability study of lithium in Alzheimer's disease [J].
Macdonald, Alastair ;
Briggs, Kate ;
Poppe, Michaela ;
Higgins, Andrea ;
Velayudhan, Latha ;
Lovestone, Simon .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (07) :704-711
[60]   Pharmacological inhibitors of glycogen synthase kinase 3 [J].
Meijer, L ;
Flajolet, M ;
Greengard, P .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (09) :471-480